4.5 Article

Is twice daily LF-rTMS a viable treatment option for treatment-resistant OCD? Results from an open-label feasibility study

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00406-020-01142-x

关键词

Obsessive-compulsive disorder; Repetitive transcranial magnetic stimulation; Safety; Efficacy

资金

  1. Concerted Research Action of Ghent University [BOF16/GOA/017]
  2. Applied Biomedical (TBM) grant of the Agency for Innovation through Science and Technology (IWT), part of the Research Foundation-Flanders (FWO) [B/14730/01]
  3. het Fonds Wetenschappelijk Onderzoek Rode Neuzen [G0F4617N]

向作者/读者索取更多资源

This study found that LF rTMS targeting the dmPFC may improve OCD, anxiety, and depressive symptoms in treatment-resistant OCD patients, and it is a safe and well-tolerated treatment.
Several reports point to the beneficial effects of repetitive transcranial magnetic stimulation (rTMS) in the treatment of resistant obsessive-compulsive disorder (OCD). This study aimed to evaluate the safety and efficacy of rTMS targeting the dmPFC in the treatment of treatment-resistant OCD patients.Twelve patients received 20 sessions of low-frequency (LF) rTMS (1 Hz, 1200 pulses) in a twice daily protocol during 10 weekdays. Y-BOCS and IDS scores modestly but significantly decreased after treatment and at follow-up and HADS anxiety improved at follow-up. LF rTMS may improve OCD, anxiety, and depressive symptoms in treatment-resistant OCD and was a safe and well-tolerated treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据